Japanese Society of
Anesthesiologists

Notification of acceptance or rejection of the submitted abstract will be sent out at the beginning of February 2027.
Please contact the secretariat if you have any questions about the notification.

Please choose one of the following themes:

• A medical system aimed at improving the quality and safety of labor analgesia.
  The implementation of labor analgesia is increasing not only in urban areas but also in various regions. With limited manpower, ensuring quality and safety is a very important issue. We are seeking presentations that could be helpful on how to conduct them not at specialized facilities but at other universities or general facilities.
• Strategies for overall management and complication measures during deep sedation (including Non-Operating Room Anesthesia)
  With the revision of medical fees in 2026, deep sedation has been approved for health insurance coverage in Japan. This is a new important issue for every facility, such as who and how to implement it, and countermeasures in the event of abnormal situations. We are seeking presentations that can serve as references for the implementation system of deep sedation at each facility through information sharing.
• Efforts to DX (Digital Transformation) of In-Hospital Operations
  As the number of surgeries increases, reforming doctors' work styles and promoting task shifting/sharing are important challenges. I believe various in-hospital operations are being DX-oriented at each facility. I thought that if we could share and incorporate specific initiatives from other facilities, we could provide useful information to our members. We look forward to proposals that can be implemented at any facility without much cost.

• 1st November 2026 12:00 noon (Japan Standard time) – Online abstract submission opens
• 1st December 2026 12:00 noon (Japan Standard time) – Online abstract submission closes

Abstracts MUST BE RECEIVED no later than December 1st, 12:00 noon (JST), 2026. Any abstracts received after the deadline will not be accepted. We encourage you to send your abstract(s) well in advance to avoid last minute rush!
You can modify your abstract during the period. But you cannot modify the information of the abstract after the deadline.

• In order to get the ID and password to log in the system you have to make your account according to the system guide.
• All abstracts can only be submitted online via the Japanese Society of the Anesthesiologists abstract submission website as of 1st Nov 2026. Abstracts submitted by mail, fax or e-mail will NOT be accepted.
• Up to 6 authors (an abstract presenter + 5 co-authors) are allowed for an abstract. The presenting author should be listed first, and (s)he will also be the contact author. Only the presenter's full name will be printed in the Program Book of the meeting.
• Please choose one of the following themes:
  • A medical system aimed at improving the quality and safety of labor analgesia
  • Strategies for overall management and complication measures during deep sedation (including Non-Operating Room Anesthesia)
  • Efforts to DX (Digital Transformation) of In-Hospital Operations
• Title should be less than 200 characters
• The abstract text should not exceed 1600 characters.
• Body of abstract: purpose of the study, methods used, summary of the results and conclusion reached.
• References should not be included in the abstract.
• One picture or simple tables may be included with the abstract. (Size: 560px×420px)
• Formulas should be avoided.
• Use standard abbreviations in parentheses after the full word the first time it appears.
• Disclosure of Conflict of Interest (Also applicable to co-authors)
• Information of Ethical matters (Committee name, Approval number, date of approval)

To submit your abstract, please use below recommend browsers and versions.

• Microsoft Edge latest version
• Firefox latest version
• Safari latest version
• Chrome latest version

Mobile phones and tablets cannot be used to submit your abstract.
Please enable Cookies and JavaScript in Your Browser.

• The work in the abstract should not be published as a scientific paper or presentation at any scientific meeting before the deadline (including online presentation and publication). If your abstract is accepted and published by another society after the submission deadline, please indicate this on the poster. (If it is presented that we cannot check the contents of the research, and it wasn't published as abstracts book etc. (Included digital media) we regard it as un-published research.)
• We will regard different research if it include only part of contents of other research or different of count of cases. And you can also present even if you have talked already at symposium.
• We allow you to submit abstract if you think it is worth it for us even if that you have presented research already at other place. In this case, you must write that it is duplicate submission. If you didn't do that, it will be regarded as presentation violation.
• Please include N and the result, statistics method in the abstract. Do not include facilities name in the abstract text nor a title for the peer review.

・Human Studies

• Prospective study (intervention study)
  It is mandatory to obtain approval from institutional ethical committee(s)* before starting the study. The investigator(s) should indicate a registration site and a registration number of all prospective clinical studies with intervention, in any part of the world.
  For clinical studies carried out in Japan, the Japanese Ministry of Health, Labor and Welfare states in the Ethical Guidelines for Medical and Health Research Involving Human Subjects that clinical trials with intervention started after June 30, 2021, in Japan must be registered in one of the following databases before recruitment of the first subject: (1) jRCT (Japan Registry of Clinical Trials) (2) UMIN Clinical Trial Registry, or (3) NIPH Clinical Trials Search.
• Prospective study (observational study)
  It is mandatory to obtain approval from institutional ethical committee(s)* before starting the study. Written informed consent (unless the ethics committees granted a waiver of it) should be obtained from all subjects or, in the case of minors, from parents. Opt-out approach could be an alternative if the ethics committee(s) approve(s) it.
• Retrospective study
  It is mandatory to obtain approval from institutional ethics committee(s)* before starting the study.
• Case report
  It is mandatory to obtain agreement for research presentation from the patient. Data related with patient identification is to be avoided in all materials. A patient must not be recognizable in any photograph.

・Animal Studies
It is mandatory to obtain approval from institutional ethical committee(s)* before starting the study.

In accordance with Regulation on application of approval for Conflict-of-Interest Policy, published in June 2010, the Japanese Society of Anesthesiologists (JSA) requires all speakers at the annual meetings of the JSA, beginning in 2010, to disclose their status of Conflict of Interest. When submitting your abstract, please declare whether there are conflicts of interest among affiliated business involved in the research and a representative speaker including coauthors and co-researchers within the past three years.

Please enter the declaration of the conflict of interest from the link below.

Regarding the disclosure of Conflict of Interest (PDF)

• Matches the theme of the call
• Have an academic significance
• The logics consist scientifically
• Based on appropriate ethic

・Oral presentation
You are requested to present your study with slides (Slides are non-limited). You have 10 minutes for presentation and 5 minutes for discussion.

During the submission period, it can be saved, edited, and revised online as many times as needed, until the submission period ends. However, it is not possible to make any corrections to the abstract content or related information (title, authors, etc.) after the submission period.

In the case of errors in the abstract discovered after the deadline, you can either withdraw the abstract or - for minor errors - may indicate the correction during the presentation at the congress. However, changes will not be included in the published version of the abstract.

All abstracts submitted for the 74th Annual Meeting of JSA are subject to peer review within the organizing committee after abstract deadline. Each abstract will be reviewed by three reviewers. The Committee's decision and guideline of poster presentation will be notified to the submitting (corresponding) author by the beginning of February in 2027 by e-mail. Please note that only the corresponding author will receive the notification e-mail and (s)he is responsible for informing all co-authors of the status of the abstract.

If a submitted abstract must be withdrawn, a written withdrawal request must be submitted to the JSA Secretariat (kouen74@anesth.or.jp) by e-mail originating from the presenter's e-mail address.

This notice must clearly mention:

• Abstract submission number;
• Title and presenter's contact data;
• Reason(s) for withdrawal of the abstract;
• Attest that all authors are in agreement that the abstract must be withdrawn.

1. Applications are accepted only through online via this website. You are required to make your account before submission.
2. The abstract submission system will get busy around the deadline of the submission. In order to submit your abstract successfully, it is highly recommended to complete your submission before the deadline.